Search results
13 de nov. de 2020 · To our knowledge, the ARREST trial is the first randomised interventional trial to assess the effect of early ECMO-facilitated resuscitation compared with standard ACLS treatment for survival of patients with out-of-hospital refractory cardiac arrest.
- Refractory cardiac arrest: when timing is crucial - The Lancet
Summary. The ARREST trial was a phase 2, single-centre,...
- Refractory cardiac arrest: when timing is crucial - The Lancet
20 de nov. de 2020 · ARREST. 20 November 2020 George Walker Emergency Medicine, Intensive Care Medicine 2 comments. Tweet. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. D Yannopoulos et al.
13 de nov. de 2020 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial - The Lancet.
25 de ene. de 2023 · The ARREST trial was terminated early because of superiority of the intervention: survival to discharge occurred in 6 of 14 patients (43%) in the group that received extracorporeal CPR as...
14 de dic. de 2020 · The ARREST trial Yannopoulos D, Bartos J, Raveendran G, Walser E, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial.
27 de ago. de 2023 · The goal of the trial was to determine whether immediate transfer to a cardiac arrest center was associated with decreased mortality compared with standard of care among field-resuscitated out-of-hospital cardiac arrest (OHCA) patients who did not have evidence of ST-segment elevation myocardial infarction (STEMI) on post-resuscitation electroca...
